Years of Ethics Charges, but Star Cancer Researcher Gets a Pass - News Summed Up

Years of Ethics Charges, but Star Cancer Researcher Gets a Pass


Dr. Croce stayed on until the council was disbanded in the industry’s more than $100 billion settlement with tobacco plaintiffs in 1998. In 1996, Dr. Croce and co-workers made international news with their discovery of a gene called the fragile histidine triad — FHIT for short. Dr. Croce’s work has linked various cancers to a deficiency or overabundance of certain microRNAs. The two had worked together on a previous project, the colleague said, and Dr. Croce appeared to have reused some of that material. “Clearly we are dealing with a mentally deranged person who should be recovered in a mental institution,” Dr. Croce wrote.


Source: New York Times March 08, 2017 09:56 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */